The thrombopoietin receptor in myeloproliferative neoplasms: A unifying mechanism of disease pathogenesis and therapeutic targeting.

Elhusseiny K, Reeves BN.

Open source

DOI
10.1053/j.seminhematol.2026.07.001
Published
2026-07-17
Container
Semin Hematol
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1053/j.seminhematol.2026.07.001,
  title = {The thrombopoietin receptor in myeloproliferative neoplasms: A unifying mechanism of disease pathogenesis and therapeutic targeting.},
  author = {Elhusseiny K and  Reeves BN.},
  year = {2026},
  journal = {Semin Hematol},
  doi = {10.1053/j.seminhematol.2026.07.001},
  url = {https://doi.org/10.1053/j.seminhematol.2026.07.001}
}

RIS

TY  - JOUR
TI  - The thrombopoietin receptor in myeloproliferative neoplasms: A unifying mechanism of disease pathogenesis and therapeutic targeting.
AU  - Elhusseiny K
AU  -  Reeves BN.
PY  - 2026
JO  - Semin Hematol
DO  - 10.1053/j.seminhematol.2026.07.001
UR  - https://doi.org/10.1053/j.seminhematol.2026.07.001
ER  - 

APA

K, E., & BN., R. (2026). The thrombopoietin receptor in myeloproliferative neoplasms: A unifying mechanism of disease pathogenesis and therapeutic targeting.. Semin Hematol. https://doi.org/10.1053/j.seminhematol.2026.07.001

Source records